Formal specification establishes industry standards for pharmaceutical implementation in oncology trials, indicating potential for unified practices.
This document is the Physical AI Oncology Trial Industry Specification and Pharmaceutical Implementation Standard (PAIOTIS) v1.0, a formal industry standard that establishes the Physical AI oncology trial industry by unifying all technical, regulatory, operational, and commercial infrastructure developed across four foundational repositories into one executable standard. Pharmaceutical and biotechnology companies can adopt this specification presented here immediately.
No takes yet. Share an insight, caveat, or question.
Kevin Kawchak (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: